Fort Wayne Medical Oncology & Hematology

What Fort Wayne Medical Oncology & Hematology does

Fort Wayne Medical Oncology and Hematology (FWMOH) is a community-based medical oncology, gynecologic oncology, and hematology practice founded in 1977 and headquartered at 2514 E Dupont Road in Fort Wayne, Indiana. The practice treats patients with more than 40 types of cancer as well as blood disorders including hemophilia, sickle cell anemia, and idiopathic thrombocytopenic purpura (ITP), delivered through 10 outpatient clinic locations across northeastern Indiana (Fort Wayne North and South, Decatur, Warsaw, Angola, Bluffton, Kendallville, Marion, and Peru). Its clinical staff includes 16 board-certified medical oncologists, 2 board-certified gynecologic oncologists, and 8 advanced practitioners, led by Dr. Praveen Kollipara (President) and Dr. Sunil Babu (Director of Research, with 70+ publications).

FWMOH operates a vertically integrated care delivery model built around three core service lines — Medical Oncology, Hematology, and Gynecologic Oncology — supported by in-house diagnostic imaging (PET/CT), centralized pathology laboratory, specialty pharmacy for oral oncolytics (with 24/7 pharmacist availability), specialty infusion services, care coordination, palliative care, and financial counseling. The Inventa Center for Cancer Research runs clinical trials including Phase 1 first-in-human studies, and the practice participates in American Oncology Network (AON), a multi-state network providing access to more than 150 clinical trials and network-wide deployment of advanced therapies such as BiTE (Bispecific T-cell Engager) immunotherapy.

The practice generates revenue through fee-for-service billing to insurance providers and patients for clinical visits, infusion therapies, diagnostic imaging, laboratory services, and pharmacy dispensing, with most major insurance plans accepted and Medicare/Medicaid participation in Indiana. Patients access FWMOH either by referral from primary care physicians or via self-referral (no referral required), with new patient appointments typically available within days. FWMOH joined American Oncology Network as a partner practice on January 7, 2025, and has expanded its geographic footprint through a partnership with Cameron Health including a renovated Regional Cancer Care Center in Angola, Indiana, that opened on March 3, 2026 with 12 infusion bays and a new linear accelerator.

Name

Fort Wayne Medical Oncology & Hematology

Legal name

Fort Wayne Medical Oncology and Hematology

Website

https://fwmoh.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

101–250 employees

Short description

Fort Wayne Medical Oncology and Hematology is a community-based medical, gynecologic, and hematologic oncology practice serving northeastern Indiana through 10 outpatient clinics, 18 physicians, and integrated lab, imaging, pharmacy, and clinical trial services.

Ownership category

akta.pro rank

Headquarters

HQ city

Fort Wayne

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Services Billing: Fee-for-service medical oncology, hematology, and gynecologic oncology services billed to insurance providers and patients
2. Specialty Infusion Services: Infusion therapies for chronic conditions including anemia, Crohn's, multiple sclerosis, rheumatoid arthritis, billed as outpatient medical services
3. Financial Counseling and Patient Assistance: Financial counseling services including patient assistance programs, payment plans, and insurance navigation support

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

FWMOH is a community-based medical oncology, gynecologic oncology, and hematology practice that diagnoses and treats more than 40 types of cancer and blood disorders. It delivers chemotherapy, immunotherapy, targeted therapy, BiTE therapy, specialty infusion, clinical trials, diagnostic imaging, in-house pathology, specialty pharmacy, palliative care, care coordination, and financial counseling across 10 outpatient clinic locations in northeastern Indiana.

Product overview

Fort Wayne Medical Oncology & Hematology is a community-based medical oncology, gynecologic oncology, and hematology practice offering a comprehensive suite of cancer and blood disorder treatment services. The practice operates as a unified healthcare delivery system with Medical Oncology, Hematology, and Gynecologic Oncology as its core clinical services, supported by integrated diagnostic and supportive services including Diagnostic Imaging, Pathology/Lab Services, Pharmacy, and Care Coordination. The Inventa Center for Cancer Research conducts clinical trials. The practice also offers specialty services including BiTE Therapy, Specialty Infusion Services, Palliative Care, and Financial Support. Partnerships with CanCare and Colla Health provide additional patient support. Since 1977, the practice has served northeastern Indiana and joined the American Oncology Network in January 2025.

Differentiator

Problem solved

Functional benefit

Brands

• Inventa Center for Cancer Research: A division of Fort Wayne Medical Oncology and Hematology that partners with leading research centers and universities to make advanced therapeutics available in FWMOH clinics, conducting clinical trials.
• CanCare
• Colla Health

Products and services

• Medical Oncology Treatment of cancer using chemotherapy, biological agents, targeted therapies, immunotherapy, and oral chemotherapy medications, delivered to community oncology patients in northeastern Indiana.
• Hematology Diagnosis and treatment of blood cancers and autoimmune disorders, including lymphoma, leukemia, myelodysplastic syndromes, multiple myeloma, and aplastic anemia, for hematology patients in northeastern Indiana.
• Gynecologic Oncology Specialized diagnosis, treatment, and support for women with cancers of the reproductive system, including ovarian, cervical, uterine, vaginal, vulvar, and endometrial cancer, delivered by board-certified gynecologic oncologists.
• Clinical Trials (Inventa Center for Cancer Research) Clinical trials division partnering with leading research centers and universities to make advanced therapeutics available locally, including Phase 1 first-in-human studies, for community oncology patients.
• BiTE Therapy Bispecific T-cell Engager (BiTE) therapy, an advanced immunotherapy that links T cells to cancer cells to boost immune response with precision and fewer side effects than traditional treatments, available to FWMOH oncology patients.
• Specialty Infusion Services Infusion-based therapies for chronic diseases including anemia, Crohn's disease, multiple sclerosis, and rheumatoid arthritis, provided under physician supervision at FWMOH clinics.
• Diagnostic Imaging On-site medical imaging including CT scans and PET/CT scans that provide precise views of internal organs, bones, soft tissues, and blood vessels for oncology patients.
• Pathology Centralized laboratory services performing routine and specialized laboratory testing with a state-of-the-art facility staffed by hematopathologists and surgical pathologists using Lean and Six Sigma process improvements.
• Pharmacy In-house specialty pharmacy services for oral oncolytic medications with 24/7 pharmacist availability, insurance assistance, and FedEx delivery for FWMOH oncology patients.
• Care Coordination & Navigation Comprehensive care coordination including symptom monitoring, medication education, nutritional guidance, barrier identification, and survivorship program support for oncology patients.
• Palliative Care Team-based palliative care including nurse practitioners, nurses, and social workers working with oncologists to manage symptoms and improve quality of life for patients with serious illness.
• Financial Support Financial counseling and patient assistance program coordination to help oncology patients navigate medical bills, insurance claims, payment plans, and patient assistance programs.

Quantifiable outcome

• Treats more than 40 types of cancer and blood disorders
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

• Cameron HealthcoreStrategic or Co-development Partner · 3 March 2026Partnership expanded in March 2026 to increase access to community-based cancer care in Angola, Indiana. FWMOH provides medical oncology, hematology, infusion therapy, and palliative care services at Cameron Health's Regional Cancer Care Center. The facility underwent full renovation including expanded lobby, 5 new exam rooms, 12 infusion bays, and new linear accelerator installation. Partnership began in 2001.
• American Oncology Network (AON)flagshipStrategic or Co-development Partner · 7 January 2025FWMOH joined American Oncology Network in January 2025, enabling expanded patient-focused services while maintaining high-quality, compassionate care. AON provides practice management expertise, integrated ancillary services, and support for growth initiatives. As part of AON's network of 290+ providers across 21 states, FWMOH gains access to clinical trials, innovative treatments like BiTE therapy, and shared best practices.
• Colla HealthminorStrategic or Co-development PartnerPartnership with Colla Health provides patients access to personalized emotional support, behavioral health services, psychiatric oversight, and targeted therapeutic interventions designed for individuals facing complex medical journeys. Services include one-on-one sessions, telehealth appointments, and personalized care plans.
• CanCareminorGTM or Marketing PartnerPartnership with CanCare nonprofit cancer support organization provides free, personal emotional support to patients and families through trained volunteer survivors and caregivers. CanCare matches patients with volunteers sharing similar diagnoses or experiences for one-on-one support.
• Parkview HealthminorStrategic or Co-development PartnerPartner in the NICC (Network Innovation in Cancer Care) partnership with FWMOH, ROA, Cameron Health, and Parkview Health allowing comprehensive cancer care services within one location next to Cameron Hospital.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• American Oncology Network: FWMOH's parent partner network (joined Jan 2025) and a fast-growing alliance of community-based oncology practices spanning 21 states with 350+ providers. Comparable as the directly relevant network aggregator shaping FWMOH's economics, clinical trial access, and growth playbook.
• City of Hope: National cancer research and treatment system (including legacy Cancer Treatment Centers of America sites) operating hospital-based oncology at greater scale and geographic breadth. Represents the academic/national-center alternative that community oncology practices like FWMOH compete against for complex cases.

Direct peers

• The US Oncology Network: A McKesson-owned national network of community oncology practices providing practice management, drug distribution, and clinical research support. Direct competitor to AON and most analogous to FWMOH's networked-community-oncology operating model.
• OneOncology: Partnership platform of community oncology practices including Tennessee Oncology, formed to negotiate payer contracts and share clinical/research infrastructure. Closely comparable to AON's value proposition for FWMOH and a likely benchmark for AON's network economics.
• Florida Cancer Specialists & Research Institute: One of the largest US community oncology practices with extensive in-house imaging, lab, pharmacy, and clinical trial capabilities across dozens of Florida sites. Closest analog to FWMOH in integrated community-oncology service model, though operating at materially greater scale.
• Tennessee Oncology: Large multi-site community oncology practice (OneOncology founding member) offering medical oncology, hematology, gynecologic oncology, infusion, imaging, and clinical research across Tennessee. Highly comparable to FWMOH in service breadth and community positioning.
• Regional Cancer Care Associates: Multi-state community oncology practice with in-office infusion, imaging, and clinical trials across the Northeast/Mid-Atlantic. Comparable mid-sized multi-site community oncology model with similar payer-mix and ancillary-service economics.
• Minnesota Oncology: Single-state community oncology practice offering medical oncology, hematology, gynecologic oncology, infusion, and clinical research across the Twin Cities metro. Comparable multi-physician, multi-site community oncology practice with research integration.
• Virginia Cancer Specialists: Large community oncology practice in Northern Virginia offering multi-disciplinary cancer care with in-house imaging, lab, clinical trials, and survivorship programs. Closely comparable mid-to-large community oncology delivery model.

Regional players

• Parkview Health: Fort Wayne-based regional health system that is both a partner (NICC collaboration with FWMOH, Cameron Health, ROA) and a competitive oncology provider in FWMOH's primary market. Most relevant local competitive and collaborative reference point.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/fwmoh
• LinkedInlinkedin.com/company/fwmoh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles26 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fort Wayne Medical Oncology & Hematology